Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Aethlon Medical Inc (AEMD)
NASDAQ:AEMD
Aethlon Medical (AEMD) Stock Price & Analysis
401 Followers
AEMD Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.40 - $7.20
Previous Close$1.44
Volume8.07K
Average Volume (3M)8.03K
Market Cap
$3.80M
Enterprise Value-$3.16M
Total Cash (Recent Filing)$7.97M
Total Debt (Recent Filing)$1.01M
Price to Earnings (P/E)-0.3
Beta1.44
Next Earnings
Jun 26, 2024EPS Estimate
-$1.26Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.02
Shares Outstanding2,620,399
10 Day Avg. Volume7,740
30 Day Avg. Volume8,032
Standard Deviation0.59
R-Squared0.03
Alpha-0.00666
Financial Highlights & Ratios
Price to Book (P/B)0.52
Price to Sales (P/S)6.62
Price to Cash Flow (P/CF)-0.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-5.51
Enterprise Value/Ebitda0.33
Forecast
1Y Price Target
$10.00Price Target Upside594.49% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Aethlon Medical News
Bulls Say, Bears Say
Bulls Say
Analyst RecommendationAntibe Therapeutics Inc. (ATE.TO) received a 'Buy' rating with anticipation for the initiation of a Phase 2 abdominoplasty study and the market's need for novel oral post-operative pain products.
Financial HealthThe company has sufficient capital to last into the future without the need for immediate fundraising.
Product DevelopmentExpecting Combination of Hemopurifier With Santersus Devices to Yield Positive Results; Combination represents a potential cancer treatment option.
Bears Say
Commercialization UncertaintyThe path to commercialization for AEMD's Hemopurifier remains uncertain, despite its technological promise.
Regulatory ChallengesThe advancement of the Hemopurifier through an accelerated regulatory pathway to approval in oncology is speculative.
Risk AssessmentThe risk profile for the Hemopurifier has been increased to a 25% probability of success, down from a previous assumption of 50%.
---
Ownership Overview
19.53% Insiders
2.70% Mutual Funds
0.81% Other Institutional Investors
76.96% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
AEMD FAQ
What was Aethlon Medical Inc’s price range in the past 12 months?
Aethlon Medical Inc lowest stock price was $1.40 and its highest was $7.20 in the past 12 months.
What is Aethlon Medical Inc’s market cap?
Currently, no data Available
When is Aethlon Medical Inc’s upcoming earnings report date?
Aethlon Medical Inc’s upcoming earnings report date is Jun 26, 2024 which is in 70 days.
How were Aethlon Medical Inc’s earnings last quarter?
Aethlon Medical Inc released its earnings results on Feb 14, 2024. The company reported -$1.37 earnings per share for the quarter, missing the consensus estimate of -$1.35 by -$0.02.
Is Aethlon Medical Inc overvalued?
According to Wall Street analysts Aethlon Medical Inc’s price is currently Undervalued.
Does Aethlon Medical Inc pay dividends?
Aethlon Medical Inc does not currently pay dividends.
What is Aethlon Medical Inc’s EPS estimate?
Aethlon Medical Inc’s EPS estimate is -$1.26.
How many shares outstanding does Aethlon Medical Inc have?
Aethlon Medical Inc has 2,620,399 shares outstanding.
What happened to Aethlon Medical Inc’s price movement after its last earnings report?
Aethlon Medical Inc reported an EPS of -$1.37 in its last earnings report, missing expectations of -$1.35. Following the earnings report the stock price went down -5.202%.
Which hedge fund is a major shareholder of Aethlon Medical Inc?
Currently, no hedge funds are holding shares in AEMD
---
Aethlon Medical Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$10.00 (594.49% Upside)
$10.00 (594.49% Upside)
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.4%
Last 30 Days ▼ 9.3%
Last 30 Days ▼ 9.3%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-63.73%
12-Months-Change
Fundamentals
Return on Equity
-98.43%
Trailing 12-Months
Asset Growth
-49.64%
Trailing 12-Months
Company Description
Aethlon Medical Inc
Aethlon Medical, Inc. is a therapeutic technology company, which focuses on addressing global health and biodefense needs. It develops Aethlon Hemopurifier, a medical device that targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The firm operates through two segments: Aethlon and ESI. The Aethlon segment involves in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce in May 1998 and is headquartered in San Diego, CA.
---
AEMD Earnings Call
Q3 2024
0:00 / 0:00
---
AEMD Stock 12 Months Forecast
Average Price Target
$10.00
▲(594.49% Upside)
Technical Analysis
Best Analysts Covering AEMD
1 Year
1 Year Success Rate
1/8 ratings generated profit
1 Year Average Return
-50.59%
reiterated a buy rating last month
Copying Vernon Bernardino's trades and holding each position for 1 Year would result in 12.50% of your transactions generating a profit, with an average return of -50.59% per trade.
---